NASDAQ:IBBQ Invesco Nasdaq Biotechnology ETF (IBBQ) Price, Holdings, & News $22.18 -0.24 (-1.05%) As of 12:12 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock About Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IBBQ alerts:Sign Up Key Stats Today's Range$22.21▼$22.5050-Day Range$21.21▼$23.1752-Week Range$20.14▼$24.84Volume1,802 shsAverage Volume17,401 shsMarket Capitalization$39.25 millionAssets Under Management$41.76 millionDividend Yield0.90%Net Expense Ratio0.19%Aggregate RatingModerate Buy ETF OverviewThe Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.Read More… Remove Ads Invesco Nasdaq Biotechnology ETF ExpensesTypeIBBQHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.19%0.57%0.56%0.53%0.53%Other Expenses0.00%0.30%0.49%0.44%0.53%Total Expense0.19%0.70%0.72%0.67%0.71%Fee Waiver0.00%-0.45%-0.50%-0.30%-0.55%Net Expense0.19%0.61%0.63%0.61%0.60% Receive IBBQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invesco Nasdaq Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address IBBQ ETF News HeadlinesInvesco Nasdaq Biotechnology ETF declares quarterly distribution of $0.04021March 24 at 6:40 PM | msn.comInvesco Nasdaq Biotechnology ETF declares quarterly distribution of $0.0619December 23, 2024 | msn.com3 Under-$10 Stocks That Could SkyrocketLooking for affordable stocks that could deliver big returns? Our latest report showcases 3 buy-rated stocks under $10 that analysts believe have major upside potential. Don’t miss out on these hidden opportunities that could boost your portfolio.March 25, 2025 | TradingTips (Ad)Invesco Launches New ETFs Targeting AI, Cybersecurity, And Defense. Here's How Some Of Their Peers Have Performed In The Past YearNovember 7, 2024 | msn.comIBBQ Invesco Nasdaq Biotechnology ETFOctober 21, 2024 | seekingalpha.comUpstream Bio valued at $1.1 bln as shares jump in Nasdaq debutOctober 11, 2024 | reuters.comSee More Headlines IBBQ ETF - Frequently Asked Questions How have IBBQ shares performed this year? Invesco Nasdaq Biotechnology ETF's stock was trading at $21.52 on January 1st, 2025. Since then, IBBQ stock has increased by 4.1% and is now trading at $22.41. View the best growth stocks for 2025 here. Who are Invesco Nasdaq Biotechnology ETF's major shareholders? Invesco Nasdaq Biotechnology ETF's top institutional shareholders include Mirae Asset Global Investments Co. Ltd. (12.60%), Strategic Financial Concepts LLC (4.46%), Strategic Financial Concepts LLC (4.46%) and Advisory Services Network LLC (3.03%). How do I buy shares of Invesco Nasdaq Biotechnology ETF? Shares of IBBQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Invesco Nasdaq Biotechnology ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Invesco Nasdaq Biotechnology ETF investors own include Vanguard Total Stock Market ETF (VTI), Verizon Communications (VZ), CrowdStrike (CRWD), DocuSign (DOCU), Meta Platforms (META), NVIDIA (NVDA) and Shopify (SHOP). Fund Details IssuerInvesco Fund NameInvesco Nasdaq Biotechnology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:IBBQ Inception Date6/11/2021 Fund ManagerPeter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser Previous SymbolNASDAQ:IBBQ WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNasdaq Biotechnology Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings266 Fund Statistics Assets Under Management$42.63 million Average Daily Volume$0.00 Discount/Premium-0.03% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorInvesco Capital Management LLC CustodianThe Bank of New York Mellon Corporation DistributorInvesco Distributors, Inc Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerLatour Trading Options OptionableN/A Short Interest3,900 shs Miscellaneous Outstanding Shares1,770,000Beta0.61 Creation Unit10,000 Creation Fee$600.00 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Top 10 IBBQ HoldingsGilead Sciences (NASDAQ:GILD)Holding Weight: 9.71%Amgen (NASDAQ:AMGN)Holding Weight: 9.34%Vertex Pharmaceuticals (NASDAQ:VRTX)Holding Weight: 9.16%Regeneron Pharmaceuticals (NASDAQ:REGN)Holding Weight: 7.02%AstraZeneca (NASDAQ:AZN)Holding Weight: 4.30%Alnylam Pharmaceuticals (NASDAQ:ALNY)Holding Weight: 3.16%Biogen (NASDAQ:BIIB)Holding Weight: 1.99%argenx (NASDAQ:ARGX)Holding Weight: 1.94%Sanofi (NASDAQ:SNY)Holding Weight: 1.70%Royalty Pharma (NASDAQ:RPRX)Holding Weight: 1.43%Full Holdings DetailsIBBQ Sector ExposureIBBQ Industry Exposure This page (NASDAQ:IBBQ) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.